Wealth Dimensions Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Hold
2,002
0.07% 126
2026
Q1
$395K Sell
2,002
-288
-13% -$55.5K 0.08% 120
2025
Q4
$421K Sell
2,290
-57
-2% -$10K 0.08% 112
2025
Q3
$360K Buy
2,347
+3
+0.1% +$454 0.07% 122
2025
Q2
$328K Sell
2,344
-87
-4% -$12.2K 0.07% 123
2025
Q1
$357K Buy
2,431
+30
+1% +$4.34K 0.09% 115
2024
Q4
$315K Sell
2,401
-297
-11% -$41.6K 0.08% 118
2024
Q3
$420K Sell
2,698
-90
-3% -$14.5K 0.11% 99
2024
Q2
$435K Sell
2,788
-19
-0.7% -$2.86K 0.12% 88
2024
Q1
$380K Buy
2,807
+264
+10% +$35K 0.11% 96
2023
Q4
$342K Buy
2,543
+63
+3% +$8.19K 0.11% 101
2023
Q3
$336K Buy
2,480
+24
+1% +$3.28K 0.12% 99
2023
Q2
$351K Sell
2,456
-3
-0.1% -$441 0.13% 99
2023
Q1
$341K Sell
2,459
-6
-0.2% -$807 0.13% 100
2022
Q4
$334K Buy
2,465
+171
+7% +$21.4K 0.14% 98
2022
Q3
$252K Buy
2,294
+16
+0.7% +$2.03K 0.12% 101
2022
Q2
$301K Buy
2,278
+42
+2% +$5.51K 0.14% 94
2022
Q1
$297K Buy
2,236
+314
+16% +$37.7K 0.14% 105
2021
Q4
$224K Buy
1,922
+13
+0.7% +$1.53K 0.11% 124
2021
Q3
$229K Buy
1,909
+31
+2% +$3.61K 0.15% 116
2021
Q2
$225K Buy
+1,878
New +$206K 0.15% 107

Other funds holding AZN

Wealth Dimensions Group's AZN Position: Q2 2026 in Review

Wealth Dimensions Group held its AstraZeneca (AZN) position steady in Q2 2026 at 2,002 shares worth $380K. The position accounts for 0.07% of the portfolio, ranked #126.

Wealth Dimensions Group first reported a position in AZN in Q2 2021 and has held it in 21 quarters since. The position peaked at $435K in Q2 2024. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Wealth Dimensions Group held 2,002 shares of AstraZeneca worth $380K as of Q2 2026.
  • Wealth Dimensions Group left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.07% of Wealth Dimensions Group's portfolio in Q2 2026, its #126 holding.
  • Wealth Dimensions Group first reported a position in AstraZeneca in Q2 2021 and has held it in 21 quarters since.
  • Wealth Dimensions Group's AstraZeneca position peaked at $435K in Q2 2024.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Wealth Dimensions Group's 13F filing for Q2 2026, filed 22 Jul 2026.